Clinical Trial Update: Phase 2b Study of GSK4532990 in Adults With NASH [Phase 2]

View source ↗

Summary

Phase 2b trial update for GSK4532990 in adults with nonalcoholic fatty liver disease, specifically nonalcoholic steatohepatitis (NASH). The study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• GSK4532990

Snippet

Sponsor: GlaxoSmithKline | Conditions: Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING